These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico. Rabelo Acevedo M; Vick MR P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683 [TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome in polycystic ovary syndrome. Carmina E Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867 [TBL] [Abstract][Full Text] [Related]
5. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician. Lorenz LB; Wild RA Clin Obstet Gynecol; 2007 Mar; 50(1):226-43. PubMed ID: 17304038 [TBL] [Abstract][Full Text] [Related]
6. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance. Bethea SW; Nestler JE Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870 [TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome in the Indian Subcontinent. Allahbadia GN; Merchant R Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079 [TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome and the metabolic syndrome. Weerakiet S J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522 [TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced? Tomlinson J; Millward A; Stenhouse E; Pinkney J Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945 [TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome in the adolescent. Pfeifer SM; Kives S Obstet Gynecol Clin North Am; 2009 Mar; 36(1):129-52. PubMed ID: 19344852 [TBL] [Abstract][Full Text] [Related]
12. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome]. Otto-Buczkowska E; Jarosz-Chobot P; Deja G Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748 [TBL] [Abstract][Full Text] [Related]
13. Role of lifestyle modification in the management of polycystic ovary syndrome. Hoeger KM Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):293-310. PubMed ID: 16772159 [TBL] [Abstract][Full Text] [Related]
14. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk in women with polycystic ovary syndrome. Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960 [TBL] [Abstract][Full Text] [Related]
16. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers. Sharma ST; Nestler JE Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):245-60. PubMed ID: 16772155 [TBL] [Abstract][Full Text] [Related]
17. The metabolic syndrome in young Korean women with polycystic ovary syndrome. Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984 [TBL] [Abstract][Full Text] [Related]